Treatment Outcomes of Esophageal Cancer

Recruiting now

Conditions studied: Esophageal Cancer

In brief

This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.

Key facts

Study ID

NCT05177393

Run by

University of California, San Francisco

People needed

2476

Starts

2019-02-28

Expected to finish

2027-06-30

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants with histopathologically confirmed or presumptive clinical diagnosis of EC. For patients who do not have histopathologically confirmed disease, presumptive clinical diagnosis may be based upon barium swallow or endoscopy without biopsy.
• Age 18 years of age or older;

You may not qualify if…

• Unable to provide informed consent

Where it is running

• Tenwek Hospital — Bomet, Kenya (enrolling)
• Moi Teaching and Referral Hospital — Eldoret, Kenya (enrolling)
• Kamuzu Central Hospital — Lilongwe, Malawi (enrolling)
• Muhimbili National Hospital — Dar es Salaam, Tanzania (enrolling)
• Ocean Road Cancer Institute — Dar es Salaam, Tanzania (enrolling)
• Kilimanjaro Christian Medical Centre — Moshi, Tanzania (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.